• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二氨四(羧酸根)合铂(IV)配合物的合成、表征及细胞毒性。

Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.

机构信息

University of Vienna, Institute of Inorganic Chemistry, Währinger Strasse 42, AT-1090 Vienna.

出版信息

Chem Biodivers. 2012 Sep;9(9):1840-8. doi: 10.1002/cbdv.201200019.

DOI:10.1002/cbdv.201200019
PMID:22976974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3499686/
Abstract

A series of eight novel diamminetetrakis(carboxylato)platinum(IV) complexes was synthesized and characterized by multinuclear (1)H-, (13)C-, (15)N-, and (195)Pt-NMR spectroscopy. Their antiproliferative potency was evaluated in three human cancer cell lines representing ovarian (CH1), lung (A549), and colon carcinoma (SW480). In cisplatin-sensitive CH1 cancer cells, cytotoxicity was found in the low micromolar range, whereas, in inherently cisplatin-resistant A549 and SW480 cells, the activity was very low or negligible. Astonishingly, raise in lipophilicity of the complexes, as found in the case of cisplatin analogs, did not result in a significant enhancement of the cytotoxic effect.

摘要

一系列八种新型的二氨四(羧酸根)合铂(IV)配合物被合成并通过多核(1)H、(13)C、(15)N 和(195)Pt-NMR 光谱进行了表征。它们的抗增殖活性在三种代表卵巢癌(CH1)、肺癌(A549)和结肠癌(SW480)的人类癌细胞系中进行了评估。在顺铂敏感的 CH1 癌细胞中,细胞毒性在低微摩尔范围内被发现,而在固有顺铂耐药的 A549 和 SW480 细胞中,活性非常低或可忽略不计。令人惊讶的是,正如顺铂类似物的情况一样,配合物亲脂性的提高并没有导致细胞毒性作用的显著增强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aaa/3499686/ecc5094c0d4e/cbdv-201200019-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aaa/3499686/bce0723f5842/cbdv-201200019-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aaa/3499686/651cb1a2fbaa/cbdv-201200019-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aaa/3499686/ecc5094c0d4e/cbdv-201200019-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aaa/3499686/bce0723f5842/cbdv-201200019-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aaa/3499686/651cb1a2fbaa/cbdv-201200019-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aaa/3499686/ecc5094c0d4e/cbdv-201200019-f2.jpg

相似文献

1
Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.二氨四(羧酸根)合铂(IV)配合物的合成、表征及细胞毒性。
Chem Biodivers. 2012 Sep;9(9):1840-8. doi: 10.1002/cbdv.201200019.
2
Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.含混合轴向配体的双(羧基)和四(羧基)铂(IV)配合物——合成、表征及细胞毒性
Chem Biodivers. 2015 Apr;12(4):559-74. doi: 10.1002/cbdv.201400291.
3
Tetracarboxylatoplatinum(IV) complexes featuring monodentate leaving groups - A rational approach toward exploiting the platinum(IV) prodrug strategy.具有单齿离去基团的四羧基铂(IV)配合物——开发铂(IV)前药策略的合理方法。
J Inorg Biochem. 2015 Dec;153:259-271. doi: 10.1016/j.jinorgbio.2015.08.018. Epub 2015 Aug 28.
4
Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin.新型双(羧基)二氯二乙胺合铂(IV)配合物的合成与表征,其细胞毒性高于顺铂。
Eur J Med Chem. 2011 Nov;46(11):5456-64. doi: 10.1016/j.ejmech.2011.09.006. Epub 2011 Sep 8.
5
Novel cis- and trans-configured bis(oxime)platinum(II) complexes: synthesis, characterization, and cytotoxic activity.新型顺式和反式双(肟)铂(II)配合物的合成、表征及细胞毒性活性。
Inorg Chem. 2010 Jun 21;49(12):5669-78. doi: 10.1021/ic100584b.
6
Novel bis(carboxylato)dichlorido(ethane-1,2-diamine)platinum(IV) complexes with exceptionally high cytotoxicity.具有极高细胞毒性的新型双(羧基)二氯(乙二胺)铂(IV)配合物。
J Inorg Biochem. 2008 Dec;102(12):2072-7. doi: 10.1016/j.jinorgbio.2008.07.006. Epub 2008 Jul 23.
7
Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.新型四羧酸根铂(IV)配合物作为卡铂前药。
Dalton Trans. 2012 Dec 21;41(47):14404-14415. doi: 10.1039/c2dt31366a.
8
Novel oximato-bridged platinum(II) di- and trimer(s): synthetic, structural, and in vitro anticancer activity studies.新型氧桥联铂(II)二聚体和三聚体的合成、结构及体外抗癌活性研究。
Inorg Chem. 2012 Jul 2;51(13):7153-63. doi: 10.1021/ic300148e. Epub 2012 Jun 12.
9
Impact of the equatorial coordination sphere on the rate of reduction, lipophilicity and cytotoxic activity of platinum(IV) complexes.赤道配位层对铂(IV)配合物还原速率、亲脂性和细胞毒性活性的影响。
J Inorg Biochem. 2017 Sep;174:119-129. doi: 10.1016/j.jinorgbio.2017.06.005. Epub 2017 Jun 16.
10
Novel endothall-containing platinum(IV) complexes: synthesis, characterization, and cytotoxic activity.新型含烯草酮的铂(IV)配合物:合成、表征及细胞毒性活性。
Chem Biodivers. 2008 Oct;5(10):2160-2170. doi: 10.1002/cbdv.200890197.

引用本文的文献

1
Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes.新型 Siglec-15-Sia 轴抑制剂通过靶向 miR-6715b-3p 和癌基因诱导结直肠癌细胞死亡。
Front Immunol. 2023 Oct 6;14:1254911. doi: 10.3389/fimmu.2023.1254911. eCollection 2023.
2
Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application.铂(IV)配合物作为新型口服抗癌候选药物的体外和体内药理学比较研究。
J Biol Inorg Chem. 2015 Jan;20(1):89-99. doi: 10.1007/s00775-014-1214-6. Epub 2014 Nov 21.
3
A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.

本文引用的文献

1
Solid-phase synthesis of oxaliplatin-TAT peptide bioconjugates.奥沙利铂-TAT 肽类生物缀合物的固相合成。
Dalton Trans. 2012 Mar 14;41(10):3001-5. doi: 10.1039/c2dt12024k. Epub 2012 Jan 27.
2
Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate.奥沙利铂的 Pt(IV)类似物,其电化学还原电位与抗坏血酸还原速率之间的相关性不符合预期。
Chem Commun (Camb). 2012 Jan 21;48(6):847-9. doi: 10.1039/c1cc16647f. Epub 2011 Nov 29.
3
Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin.
一类新型的双螯合和三螯合二(多)胺双(二羧基)铂(IV)配合物作为潜在的抗癌前药。
J Med Chem. 2014 Aug 14;57(15):6751-64. doi: 10.1021/jm500791c. Epub 2014 Jul 30.
4
Synthetic methods for the preparation of platinum anticancer complexes.铂类抗癌配合物的合成方法。
Chem Rev. 2014 Apr 23;114(8):4470-95. doi: 10.1021/cr4004314. Epub 2013 Nov 27.
新型双(羧基)二氯二乙胺合铂(IV)配合物的合成与表征,其细胞毒性高于顺铂。
Eur J Med Chem. 2011 Nov;46(11):5456-64. doi: 10.1016/j.ejmech.2011.09.006. Epub 2011 Sep 8.
4
Mono-carboxylated diaminedichloridoplatinum(IV) complexes--selective synthesis, characterization, and cytotoxicity.单羧基二胺二氯合铂(IV)配合物的选择性合成、表征和细胞毒性。
Dalton Trans. 2011 Aug 28;40(32):8187-92. doi: 10.1039/c1dt10301f. Epub 2011 Jul 11.
5
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes.合成、表征及铂(IV)氨基甲酸酯配合物的细胞毒性。
Inorg Chem. 2011 Apr 4;50(7):3103-15. doi: 10.1021/ic2000816. Epub 2011 Mar 1.
6
Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes.通过抗癌铂(IV)配合物的结构变化来调节亲脂性和细胞毒性效力。
J Inorg Biochem. 2011 Jan;105(1):46-51. doi: 10.1016/j.jinorgbio.2010.09.006. Epub 2010 Oct 1.
7
The first example of MEEKC-ICP-MS coupling and its application for the analysis of anticancer platinum complexes.微乳液电动色谱-电感耦合等离子体质谱联用及其在抗癌铂配合物分析中的应用。
Electrophoresis. 2010 Apr;31(7):1144-1150. doi: 10.1002/elps.200900522.
8
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.米托铂,顺铂与孤儿药二氯乙酸盐的强力融合物。
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22199-204. doi: 10.1073/pnas.0912276106. Epub 2009 Dec 10.
9
Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor Agents.动力学惰性铂(IV)羟基配合物的羧化反应。迈向口服活性铂(IV)抗肿瘤药物的插曲。
Inorg Chem. 1995 Mar;34(5):1015-21. doi: 10.1021/ic00109a004.
10
Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads.多价寡核苷酸金纳米粒子缀合物作为铂(IV)弹头的递送载体。
J Am Chem Soc. 2009 Oct 21;131(41):14652-3. doi: 10.1021/ja9071282.